Elevated Triglyceride Levels and Later Type 2 Diabetes

Type 2 Diabetes Clinical Trial

Official title:

Elevated Triglyceride Levels and Later Type 2 Diabetes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01182935
• Other study ID #: UIT-ENDO-2010-3
• Status: Completed
• Phase: N/A
• First received: August 11, 2010
• Last updated: July 19, 2011
• Start date: April 2010
• Est. completion date: November 2010

Study information

• Verified date: July 2011
• Source: University of Tromso
• Contact: n/a
• Is FDA regulated: No
• Health authority: Norway:National Committee for Medical and Health Research Ethics
• Study type: Observational

Clinical Trial Summary

Subjects with elevated serum triglycerides in the 4th Tromso study in 1994/1995 were re-examined with an oral glucose tolerance test to see predictive value of triglycerides regarding development of type 2 diabetes

Recruitment information / eligibility

• Status: Completed
• Enrollment: 3509
• Est. completion date: November 2010
• Est. primary completion date: September 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 20 Years to 80 Years

Eligibility

Inclusion Criteria:

• participants in the 4 Tromso study 1994 and with elevated serum triglyceride levels

Exclusion Criteria:

• type 2 diabetes

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Diabetes Mellitus, Type 2
• Hypertriglyceridemia
• Type 2 Diabetes

Locations

Country	Name	City	State
Norway	Univesity of Tromsø	Tromsø

Sponsors (1)

Lead Sponsor	Collaborator
University of Tromso

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of subjects with type 2 diabetes diagnosed with oral glucose tolerance test (OGTT)		At study enrollment in 2010	No
Secondary	The relation between serum 25(OH)D levels and blood glucose levels at OGTT		At study enrollment in 2010	No